Legacy Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Sell
568
-455
-44% -$218K 0.12% 107
2026
Q1
$503K Buy
1,023
+616
+151% +$334K 0.26% 43
2025
Q4
$236K Buy
+407
New +$230K 0.16% 73

Other funds holding TMO

Legacy Wealth Advisors's TMO Position: Q2 2026 in Review

Legacy Wealth Advisors reduced its Thermo Fisher Scientific (TMO) stake by 44% in Q2 2026, selling an estimated $218K and leaving 568 shares worth $285K. The position accounts for 0.12% of the portfolio, ranked #107.

Legacy Wealth Advisors first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. The position peaked at $503K in Q1 2026. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Legacy Wealth Advisors held 568 shares of Thermo Fisher Scientific worth $285K as of Q2 2026.
  • Legacy Wealth Advisors sold 455 Thermo Fisher Scientific shares in Q2 2026, an estimated $218K.
  • Thermo Fisher Scientific made up 0.12% of Legacy Wealth Advisors's portfolio in Q2 2026, its #107 holding.
  • Legacy Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • Legacy Wealth Advisors's Thermo Fisher Scientific position peaked at $503K in Q1 2026.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legacy Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.